{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:16:35Z","timestamp":1781914595056,"version":"3.54.5"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010892","name":"Department of Science and Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010892","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004541","name":"Ministry of Human Resource Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12936-017-1937-2","type":"journal-article","created":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T13:21:29Z","timestamp":1500384089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Exploring anti-malarial potential of FDA approved drugs: an in silico approach"],"prefix":"10.1186","volume":"16","author":[{"given":"Gayatri","family":"Ramakrishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagasuma","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6566-6239","authenticated-orcid":false,"given":"Narayanaswamy","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,18]]},"reference":[{"key":"1937_CR1","volume-title":"World Malaria Report 2014","author":"WHO","year":"2014","unstructured":"WHO. World Malaria Report 2014. Geneva: World Health Organization; 2014."},{"key":"1937_CR2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.tips.2006.09.005","volume":"27","author":"SG Valderramos","year":"2006","unstructured":"Valderramos SG, Fidock DA. Transporters involved in resistance to antimalarial drugs. Trends Pharmacol Sci. 2006;27:594\u2013601.","journal-title":"Trends Pharmacol Sci"},{"key":"1937_CR3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro2385","volume":"8","author":"AM Dondorp","year":"2010","unstructured":"Dondorp AM, Yeung S, White L, Nguon C, Day NP, Socheat D, et al. Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol. 2010;8:272\u201380.","journal-title":"Nat Rev Microbiol"},{"key":"1937_CR4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pt.2010.09.004","volume":"27","author":"R Jambou","year":"2011","unstructured":"Jambou R, Le Bras J, Randrianarivelojosia M. Pitfalls in new artemisinin-containing antimalarial drug development. Trends Parasitol. 2011;27:82\u201390.","journal-title":"Trends Parasitol"},{"key":"1937_CR5","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.4155\/fmc.11.95","volume":"3","author":"A Nzila","year":"2011","unstructured":"Nzila A, Ma Z, Chibale K. Drug repositioning in the treatment of malaria and TB. Future Med Chem. 2011;3:1413\u201326.","journal-title":"Future Med Chem"},{"key":"1937_CR6","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1126\/science.1205216","volume":"333","author":"J Yuan","year":"2011","unstructured":"Yuan J, Cheng KC, Johnson RL, Huang R, Pattaradilokrat S, Liu A, et al. Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets. Science. 2011;333:724\u20139.","journal-title":"Science"},{"key":"1937_CR7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/1475-2875-12-359","volume":"12","author":"H Matthews","year":"2013","unstructured":"Matthews H, Usman-Idris M, Khan F, Read M, Nirmalan N. Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate. Malar J. 2013;12:359.","journal-title":"Malar J"},{"key":"1937_CR8","doi-asserted-by":"crossref","first-page":"e0135556","DOI":"10.1371\/journal.pone.0135556","volume":"10","author":"M Kaiser","year":"2015","unstructured":"Kaiser M, Maser P, Tadoori LP, Ioset JR, Brun R. Antiprotozoal activity profiling of approved drugs: a starting point toward drug repositioning. PLoS ONE. 2015;10:e0135556.","journal-title":"PLoS ONE"},{"key":"1937_CR9","doi-asserted-by":"crossref","first-page":"e1002333","DOI":"10.1371\/journal.pcbi.1002333","volume":"8","author":"FA Kruger","year":"2012","unstructured":"Kruger FA, Overington JP. Global analysis of small molecule binding to related protein targets. PLoS Comput Biol. 2012;8:e1002333.","journal-title":"PLoS Comput Biol"},{"key":"1937_CR10","doi-asserted-by":"crossref","first-page":"D539","DOI":"10.1093\/nar\/gkn814","volume":"37","author":"C Aurrecoechea","year":"2009","unstructured":"Aurrecoechea C, Brestelli J, Brunk BP, Dommer J, Fischer S, Gajria B, et al. PlasmoDB: a functional genomic database for malaria parasites. Nucleic Acids Res. 2009;37:D539\u201343.","journal-title":"Nucleic Acids Res"},{"key":"1937_CR11","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1021\/pr400394g","volume":"12","author":"BN Pease","year":"2013","unstructured":"Pease BN, Huttlin EL, Jedrychowski MP, Talevich E, Harmon J, Dillman T, et al. Global analysis of protein expression and phosphorylation of three stages of Plasmodium falciparum intraerythrocytic development. J Proteome Res. 2013;12:4028\u201345.","journal-title":"J Proteome Res"},{"key":"1937_CR12","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nature01107","volume":"419","author":"L Florens","year":"2002","unstructured":"Florens L, Washburn MP, Raine JD, Anthony RM, Grainger M, Haynes JD, et al. A proteomic view of the Plasmodium falciparum life cycle. Nature. 2002;419:520\u20136.","journal-title":"Nature"},{"key":"1937_CR13","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1087025","volume":"301","author":"KG Roch Le","year":"2003","unstructured":"Le Roch KG, Zhou Y, Blair PL, Grainger M, Moch JK, Haynes JD, et al. Discovery of gene function by expression profiling of the malaria parasite life cycle. Science. 2003;301:1503\u20138.","journal-title":"Science"},{"key":"1937_CR14","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1074\/mcp.M112.024505","volume":"12","author":"SE Lindner","year":"2013","unstructured":"Lindner SE, Swearingen KE, Harupa A, Vaughan AM, Sinnis P, Moritz RL, et al. Total and putative surface proteomics of malaria parasite salivary gland sporozoites. Mol Cell Proteomics. 2013;12:1127\u201343.","journal-title":"Mol Cell Proteomics"},{"key":"1937_CR15","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1074\/mcp.M900479-MCP200","volume":"9","author":"F Silvestrini","year":"2010","unstructured":"Silvestrini F, Lasonder E, Olivieri A, Camarda G, van Schaijk B, Sanchez M, et al. Protein export marks the early phase of gametocytogenesis of the human malaria parasite Plasmodium falciparum. Mol Cell Proteomics. 2010;9:1437\u201348.","journal-title":"Mol Cell Proteomics"},{"key":"1937_CR16","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1039\/C5MB00476D","volume":"11","author":"G Ramakrishnan","year":"2015","unstructured":"Ramakrishnan G, Chandra NR, Srinivasan N. Recognizing drug targets using evolutionary information: implications for repurposing FDA-approved drugs against Mycobacterium tuberculosis H37Rv. Mol BioSyst. 2015;11:3316\u201331.","journal-title":"Mol BioSyst"},{"key":"1937_CR17","doi-asserted-by":"crossref","first-page":"e1002195","DOI":"10.1371\/journal.pcbi.1002195","volume":"7","author":"SR Eddy","year":"2011","unstructured":"Eddy SR. Accelerated Profile HMM Searches. PLoS Comput Biol. 2011;7:e1002195.","journal-title":"PLoS Comput Biol"},{"key":"1937_CR18","doi-asserted-by":"crossref","first-page":"D465","DOI":"10.1093\/nar\/gkq1091","volume":"39","author":"U Pieper","year":"2011","unstructured":"Pieper U, Webb BM, Barkan DT, Schneidman-Duhovny D, Schlessinger A, Braberg H, et al. ModBase, a database of annotated comparative protein structure models, and associated resources. Nucleic Acids Res. 2011;39:D465\u201374.","journal-title":"Nucleic Acids Res"},{"key":"1937_CR19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","volume":"234","author":"A Sali","year":"1993","unstructured":"Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993;234:779\u2013815.","journal-title":"J Mol Biol"},{"key":"1937_CR20","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1110\/ps.062416606","volume":"15","author":"MY Shen","year":"2006","unstructured":"Shen MY, Sali A. Statistical potential for assessment and prediction of protein structures. Protein Sci. 2006;15:2507\u201324.","journal-title":"Protein Sci"},{"key":"1937_CR21","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1093\/nar\/gki524","volume":"33","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Skolnick J. TM-align: a protein structure alignment algorithm based on the TM-score. Nucleic Acids Res. 2005;33:2302\u20139.","journal-title":"Nucleic Acids Res"},{"key":"1937_CR22","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/bioinformatics\/btq066","volume":"26","author":"J Xu","year":"2010","unstructured":"Xu J, Zhang Y. How significant is a protein structure similarity with TM-score\u00a0=\u00a00.5? Bioinformatics. 2010;26:889\u201395.","journal-title":"Bioinformatics"},{"key":"1937_CR23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature01097","volume":"419","author":"MJ Gardner","year":"2002","unstructured":"Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature. 2002;419:498\u2013511.","journal-title":"Nature"},{"key":"1937_CR24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/1871526510909030257","volume":"9","author":"N Tyagi","year":"2009","unstructured":"Tyagi N, Swapna LS, Mohanty S, Agarwal G, Gowri VS, Anamika K, et al. Evolutionary divergence of Plasmodium falciparum: sequences, protein\u2013protein interactions, pathways and processes. Infect Disord Drug Targets. 2009;9:257\u201371.","journal-title":"Infect Disord Drug Targets"},{"key":"1937_CR25","first-page":"226","volume-title":"Frontiers in protein and peptide sciences","author":"S Mohanty","year":"2014","unstructured":"Mohanty S, Ramakrishnan G, Dave P, Srinivasan N. Analysis of sequence divergence in metabolic proteins of Plasmodium falciparum: implications for remote homology detection. In: Dunn BM, editor. Frontiers in protein and peptide sciences. Emirate of Sharjah: Bentham Science Publishers; 2014. p. 226\u201372."},{"key":"1937_CR26","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34:D668\u201372.","journal-title":"Nucleic Acids Res"},{"key":"1937_CR27","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1073\/pnas.1011560108","volume":"108","author":"ES Istvan","year":"2011","unstructured":"Istvan ES, Dharia NV, Bopp SE, Gluzman I, Winzeler EA, Goldberg DE. Validation of isoleucine utilization targets in Plasmodium falciparum. Proc Natl Acad Sci USA. 2011;108:1627\u201332.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1937_CR28","doi-asserted-by":"crossref","first-page":"D1083","DOI":"10.1093\/nar\/gkt1031","volume":"42","author":"AP Bento","year":"2014","unstructured":"Bento AP, Gaulton A, Hersey A, Bellis LJ, Chambers J, Davies M, et al. The ChEMBL bioactivity database: an update. Nucleic Acids Res. 2014;42:D1083\u201390.","journal-title":"Nucleic Acids Res"},{"key":"1937_CR29","unstructured":"ChEMBL. 2017. https:\/\/www.ebi.ac.uk\/chembl\/ . Accessed 20 Jan 2016."},{"key":"1937_CR30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1021\/jm00121a028","volume":"32","author":"LL Klein","year":"1989","unstructured":"Klein LL, Yeung CM, Kurath P, Mao JC, Fernandes PB, Lartey PA, et al. Synthesis and activity of nonhydrolyzable pseudomonic acid analogues. J Med Chem. 1989;32:151\u201360.","journal-title":"J Med Chem"},{"key":"1937_CR31","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1021\/jm960738k","volume":"40","author":"P Brown","year":"1997","unstructured":"Brown P, Best DJ, Broom NJ, Cassels R, O\u2019Hanlon PJ, Mitchell TJ, et al. The chemistry of pseudomonic acid. 18. Heterocyclic replacement of the alpha, beta-unsaturated ester: synthesis, molecular modeling, and antibacterial activity. J Med Chem. 1997;40:2563\u201370.","journal-title":"J Med Chem"},{"key":"1937_CR32","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/nsb1196-912","volume":"3","author":"CR Dunn","year":"1996","unstructured":"Dunn CR, Banfield MJ, Barker JJ, Higham CW, Moreton KM, Turgut-Balik D, et al. The structure of lactate dehydrogenase from Plasmodium falciparum reveals a new target for anti-malarial design. Nat Struct Biol. 1996;3:912\u20135.","journal-title":"Nat Struct Biol"},{"key":"1937_CR33","doi-asserted-by":"crossref","first-page":"10213","DOI":"10.1074\/jbc.274.15.10213","volume":"274","author":"JA Read","year":"1999","unstructured":"Read JA, Wilkinson KW, Tranter R, Sessions RB, Brady RL. Chloroquine binds in the cofactor binding site of Plasmodium falciparum lactate dehydrogenase. J Biol Chem. 1999;274:10213\u20138.","journal-title":"J Biol Chem"},{"key":"1937_CR34","doi-asserted-by":"crossref","first-page":"13256","DOI":"10.1074\/jbc.M409652200","volume":"280","author":"PR Race","year":"2005","unstructured":"Race PR, Lovering AL, Green RM, Ossor A, White SA, Searle PF, et al. Structural and mechanistic studies of Escherichia coli nitroreductase with the antibiotic nitrofurazone. Reversed binding orientations in different redox states of the enzyme. J Biol Chem. 2005;280:13256\u201364.","journal-title":"J Biol Chem"},{"key":"1937_CR35","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004;47:1739\u201349.","journal-title":"J Med Chem"},{"key":"1937_CR36","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem. 2004;47:1750\u20139.","journal-title":"J Med Chem"},{"key":"1937_CR37","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem. 2006;49:6177\u201396.","journal-title":"J Med Chem"},{"key":"1937_CR38","first-page":"79","volume":"106","author":"I Subbayya","year":"1997","unstructured":"Subbayya I, Ray S, Balaram P, Balaram H. Metabolic enzymes as potential drug targets in Plasmodium falciparum. Indian J Med Res. 1997;106:79.","journal-title":"Indian J Med Res"},{"key":"1937_CR39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1054\/drup.2001.0205","volume":"4","author":"SA Ralph","year":"2001","unstructured":"Ralph SA, D\u2019Ombrain MC, McFadden GI. The apicoplast as an antimalarial drug target. Drug Resist Updates. 2001;4:145\u201351.","journal-title":"Drug Resist Updates"},{"key":"1937_CR40","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pt.2006.04.008","volume":"22","author":"H Ginsburg","year":"2006","unstructured":"Ginsburg H. Progress in in silico functional genomics: the malaria metabolic pathways database. Trends Parasitol. 2006;22:238\u201340.","journal-title":"Trends Parasitol"},{"key":"1937_CR41","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1517\/17460441.2012.714363","volume":"7","author":"JA Arnott","year":"2012","unstructured":"Arnott JA, Planey SL. The influence of lipophilicity in drug discovery and design. Exp Opin Drug Discov. 2012;7:863\u201375.","journal-title":"Exp Opin Drug Discov"},{"key":"1937_CR42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46:3\u201326.","journal-title":"Adv Drug Deliv Rev"},{"key":"1937_CR43","doi-asserted-by":"crossref","first-page":"e59288","DOI":"10.1371\/journal.pone.0059288","volume":"8","author":"NA Bispo","year":"2013","unstructured":"Bispo NA, Culleton R, Silva LA, Cravo P. A systematic in silico search for target similarity identifies several approved drugs with potential activity against the Plasmodium falciparum apicoplast. PLoS ONE. 2013;8:e59288.","journal-title":"PLoS ONE"},{"key":"1937_CR44","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/cmdc.200600240","volume":"2","author":"M Schlitzer","year":"2007","unstructured":"Schlitzer M. Malaria chemotherapeutics part I: history of antimalarial drug development, currently used therapeutics, and drugs in clinical development. ChemMedChem. 2007;2:944\u201386.","journal-title":"ChemMedChem"},{"key":"1937_CR45","unstructured":"ChemAxon. 2017. https:\/\/www.chemaxon.com\/ . Accessed 20 Jan 2016."},{"key":"1937_CR46","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1371\/journal.pgen.0010036","volume":"1","author":"W Li","year":"2005","unstructured":"Li W, Mo W, Shen D, Sun L, Wang J, Lu S, et al. Yeast model uncovers dual roles of mitochondria in action of artemisinin. PLoS Genet. 2005;1:e36.","journal-title":"PLoS Genet"},{"key":"1937_CR47","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1054-3589(08)60952-7","volume":"37","author":"JN Cumming","year":"1997","unstructured":"Cumming JN, Ploypradith P, Posner GH. Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action. Adv Pharmacol. 1997;37:253\u201397.","journal-title":"Adv Pharmacol"},{"key":"1937_CR48","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.actatropica.2006.10.008","volume":"100","author":"S Nakornchai","year":"2006","unstructured":"Nakornchai S, Konthiang P. Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro. Acta Trop. 2006;100:185\u201391.","journal-title":"Acta Trop"},{"key":"1937_CR49","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1128\/AAC.41.10.2261","volume":"41","author":"E Amukoye","year":"1997","unstructured":"Amukoye E, Winstanley PA, Watkins WM, Snow RW, Hatcher J, Mosobo M, et al. Chlorproguanil\u2013dapsone: effective treatment for uncomplicated falciparum malaria. Antimicrob Agents Chemother. 1997;41:2261\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"1937_CR50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/jama.1969.03150140080016","volume":"207","author":"SJ Berman","year":"1969","unstructured":"Berman SJ. Chloroquine-pyrimethamine-sulfisoxazole therapy of Plasmodium falciparum malaria. An alternative to quinine. JAMA. 1969;207:128\u201330.","journal-title":"JAMA"},{"key":"1937_CR51","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4269\/ajtmh.1952.1.936","volume":"1","author":"F Ruiz-Sanchez","year":"1952","unstructured":"Ruiz-Sanchez F, Quezada M, Paredes M, Casillas J, Riebeling R. Chloramphenicol in malaria. Am J Trop Med Hyg. 1952;1:936\u201340.","journal-title":"Am J Trop Med Hyg"},{"key":"1937_CR52","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1128\/AAC.32.8.1182","volume":"32","author":"AA Divo","year":"1988","unstructured":"Divo AA, Sartorelli AC, Patton CL, Bia FJ. Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro. Antimicrob Agents Chemother. 1988;32:1182\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"1937_CR53","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0035-9203(97)90035-3","volume":"91","author":"TS Skinner-Adams","year":"1997","unstructured":"Skinner-Adams TS, Davis TM, Manning LS, Johnston WA. The efficacy of benzimidazole drugs against Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg. 1997;91:580\u20134.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1937_CR54","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/1475-2875-13-414","volume":"13","author":"R Sahu","year":"2014","unstructured":"Sahu R, Walker LA, Tekwani BL. In vitro and in vivo anti-malarial activity of tigecycline, a glycylcycline antibiotic, in combination with chloroquine. Malar J. 2014;13:414.","journal-title":"Malar J"},{"key":"1937_CR55","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1128\/AAC.45.6.1746-1750.2001","volume":"45","author":"B Pradines","year":"2001","unstructured":"Pradines B, Rogier C, Fusai T, Mosnier J, Daries W, Barret E, et al. In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron. Antimicrob Agents Chemother. 2001;45:1746\u201350.","journal-title":"Antimicrob Agents Chemother"},{"key":"1937_CR56","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/jac\/dkn330","volume":"62","author":"M Sousa","year":"2008","unstructured":"Sousa M, Pozniak A, Boffito M. Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs. J Antimicrob Chemother. 2008;62:872\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"1937_CR57","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0035-9203(87)90226-4","volume":"81","author":"E Petersen","year":"1987","unstructured":"Petersen E. In vitro susceptibility of Plasmodium falciparum malaria to pyrimethamine, sulfadoxine, trimethoprim and sulfamethoxazole, singly and in combination. Trans R Soc Trop Med Hyg. 1987;81:238\u201341.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1937_CR58","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1128\/AAC.47.8.2636-2639.2003","volume":"47","author":"N Mahmoudi","year":"2003","unstructured":"Mahmoudi N, Ciceron L, Franetich JF, Farhati K, Silvie O, Eling W, et al. In vitro activities of 25 quinolones and fluoroquinolones against liver and blood stage Plasmodium spp. Antimicrob Agents Chemother. 2003;47:2636\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"1937_CR59","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1128\/AAC.00892-07","volume":"52","author":"D Barthel","year":"2008","unstructured":"Barthel D, Schlitzer M, Pradel G. Telithromycin and quinupristin\u2013dalfopristin induce delayed death in Plasmodium falciparum. Antimicrob Agents Chemother. 2008;52:774\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"1937_CR60","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.molbiopara.2013.10.003","volume":"192","author":"A Gupta","year":"2013","unstructured":"Gupta A, Mir SS, Saqib U, Biswas S, Vaishya S, Srivastava K, et al. The effect of fusidic acid on Plasmodium falciparum elongation factor G (EF-G). Mol Biochem Parasitol. 2013;192:39\u201348.","journal-title":"Mol Biochem Parasitol"},{"key":"1937_CR61","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/84612","volume":"7","author":"N Surolia","year":"2001","unstructured":"Surolia N, Surolia A. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nat Med. 2001;7:167\u201373.","journal-title":"Nat Med"},{"key":"1937_CR62","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(10)60396-0","volume":"376","author":"L Luzzatto","year":"2010","unstructured":"Luzzatto L. The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics. Lancet. 2010;376:739\u201341.","journal-title":"Lancet"},{"key":"1937_CR63","doi-asserted-by":"crossref","first-page":"495863","DOI":"10.1155\/2009\/495863","volume":"2009","author":"DM Mintzer","year":"2009","unstructured":"Mintzer DM, Billet SN, Chmielewski L. Drug-induced hematologic syndromes. Adv Hematol. 2009;2009:495863.","journal-title":"Adv Hematol"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-017-1937-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T02:42:43Z","timestamp":1589769763000},"score":1,"resource":{"primary":{"URL":"http:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-017-1937-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,18]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1937"],"URL":"https:\/\/doi.org\/10.1186\/s12936-017-1937-2","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,18]]},"article-number":"290"}}